News
See what has been written about us in the press as well as news of our developments. If you would like further information on the company, our people and innovations, please contact us.2010-05-17
Nanologica will within CODIRECT work on its technological platform NlabInside that delivers active molecules within the field of nutrition, taste and fragrances.
Effective kontroll of delivery and release of functional and aktive ingrediens ill improve and effectivise many areas of applikation. The control will reduce the unwanted bi-effects as for example overdose and delivery at the wrong time and place.
”It is very exciting and honoring for Nanologica to be included in this group of prestigious industriell and academic partners. It is also a great recognition for the company and it shows that our materials are of the highest relevance for the development of new effective systems for active molecules as pharmaceuticals, fragrances and tastes", says Krim Talia, VD Nanologica.
The innovation results will be used in applications within a number of areas as for example environment, pharmaceuticals and the industrial sector. The program is financed by Vinnova, the Swedish Foundation for Strategic Research and the Knowledge Foundation as well as the industry.
Nanologica joins CODIRECT as an industrial partner
Nanologica takes an aktive role as an industriell partner to CODIRECT, an excellence center led by YKI (Institute for Surface Chemistry). Other industrial partners are Akzo Nobel Group, Colgate-Palmolive, Kraft Foods Global and Procter & Gamble.Nanologica will within CODIRECT work on its technological platform NlabInside that delivers active molecules within the field of nutrition, taste and fragrances.
Effective kontroll of delivery and release of functional and aktive ingrediens ill improve and effectivise many areas of applikation. The control will reduce the unwanted bi-effects as for example overdose and delivery at the wrong time and place.
”It is very exciting and honoring for Nanologica to be included in this group of prestigious industriell and academic partners. It is also a great recognition for the company and it shows that our materials are of the highest relevance for the development of new effective systems for active molecules as pharmaceuticals, fragrances and tastes", says Krim Talia, VD Nanologica.
The innovation results will be used in applications within a number of areas as for example environment, pharmaceuticals and the industrial sector. The program is financed by Vinnova, the Swedish Foundation for Strategic Research and the Knowledge Foundation as well as the industry.
2010-04-29
Nanologica has during the last five years developed a unique and cost-effective technology for drug delivery through a patented material that improves the oral absorption and dosage regimen of marketed and candidate drugs that otherwise are poorly absorved or cannot be fully developed into medicines. More over, NLAB Biosciencesmaterials allow gastric pH independent oral drug delivery, making oral absoprtion less variable between individuals and avoiding negative drug-drug interactions with gastric pH inhibitors. The technology has been tested and has an estimated market value of over €5 billion.
"We see a good fit between our technology platform, NLAB particle, and the challenges that the pharmaceutical industry is facing with increasing development costs and regulatory barriers for approval of new medicines. Nanologica's technology, NLAB particle, makes it possible for pharmaceutical companies to reposition their product portfolio and give prolonged protection to their successful products as well as enabling the progression of new molecules currently in development", says Krim Talia, CEO Nanologica
Nanologica starts a daughter company in Spain - NLAB BioSciences
NLAB BioSciences has started to exploit Nanologica's technology platform NLAB particle within the pharmaceutical and biotech sectors with an initial focus on DRUG DELIVERY.Nanologica has during the last five years developed a unique and cost-effective technology for drug delivery through a patented material that improves the oral absorption and dosage regimen of marketed and candidate drugs that otherwise are poorly absorved or cannot be fully developed into medicines. More over, NLAB Biosciencesmaterials allow gastric pH independent oral drug delivery, making oral absoprtion less variable between individuals and avoiding negative drug-drug interactions with gastric pH inhibitors. The technology has been tested and has an estimated market value of over €5 billion.
"We see a good fit between our technology platform, NLAB particle, and the challenges that the pharmaceutical industry is facing with increasing development costs and regulatory barriers for approval of new medicines. Nanologica's technology, NLAB particle, makes it possible for pharmaceutical companies to reposition their product portfolio and give prolonged protection to their successful products as well as enabling the progression of new molecules currently in development", says Krim Talia, CEO Nanologica
2010-03-24
"We believe that new materials will be the driving forces behind the next industrial revolution. New materials gives us possibilties to reach further, faster and to a lower cost without wasting our world's limited resources. Nanologica's contribution is a number of new nano materials that will change the game plan with several important areas", says Krim Talia, CEO Nanologica
Nanologica is recognised as one of Sweden's hottest technology companies
Nanologica is nominated as one of Sweden's most promising technology companies in the yearly awards ceremoy held by Affärsvärlden and Ny Teknik."We believe that new materials will be the driving forces behind the next industrial revolution. New materials gives us possibilties to reach further, faster and to a lower cost without wasting our world's limited resources. Nanologica's contribution is a number of new nano materials that will change the game plan with several important areas", says Krim Talia, CEO Nanologica
09.07.16
"It is highly honorable that our work gets attention internationally. We have for several years worked with leading international academic and industrial partners and customers and it feels good that this work is now recognized by the World Technology Network", says Krim Talia, CEO Nanologica
Nanologica is a materials development company specializing in developing innovative nano-porous materials for a variety of applications (from Diagnostics and Drug Delivery to Solar cells). The company was founded in Uppsala in 2004 and its unique technology is based on nanotechnology research from Stockholm University and the Ångström Laboratory at Uppsala University. Nanologica's technology enables the creation of nano-porous materials with new properties as a function of material composition, size, and structure.
The importance of materials stuctures can be observed around us every day. An interesting example is carbon, depending on the atomic structure it can take the form of graphite (which is one of the softest existing substances) or diamond (which is one of the hardest). Achievements in nanotechnology allows scientists to, by intelligent design of materials on an atomic level, create materials with superior properties for specific target applications.
"We have with the support from Vinnova, Innovationsbron and a number of bold business angels taken our fundamentally new research from innovation to commercially viable products - a process that requires both research excellence and business sustainability. We have now reached a commercial breakthrough in a number of our application areas, and this nomination is proof that we draw attention far beyond the borders of Sweden", says Krim Talia, CEO Nanologica
Nanologica is developing materials for applications for the health-care and energy sectors. Nanologica's materials are used in diagnostic applications where nano porous particles have been functionlised with different fluorescent molecules that are then conjugated with antibodies to act as markers in diagnostic tests and analysis. Nanologica's material is also used as substrate for drug delivery in a collaborative project with one of the world's five largest pharmaceutical companies. The specific Nanologica material that is used in this process is called In vivo, and is now tested for constructing molecules that require a controlled delivery over a longer period than one week.
For the energy sector Nanologica has developed and patented materials and technology that significantly increases the efficiency of third generation solar cells. Nanologica material creates a turbo efficient in transparent DSSC solar cells which opens up new opportunities for integration of solar cells in for example skyscrapers and translucent windows applications. This technology has an important role to play in the overall trend towards environmentally sustainable buildings. The technology is commercialised by the Nanologica subsidiary NLAB Solar. For more information visit www.nlabsolar.com ;
World Technology Network (WTN) is in association with TIME magazine, Fortune magazine, Science magazine, the NASDAQ / OMX, Mayo Clinic, Advance Science Serving Society and the New York Academy of Sciences. WTN consists of 1,000 members from 60 countries. Its members are focused on the business and science of bringing important emerging technologies of all types (from biotech to new materials, from IT to new energy sources) into reality. WTN was created to encourage serendipity and is an elite network of people working to change the world. For more information visit www.wtn.net ;
Nominated in the category Materials (corporate):
Cambrios Technologies, Canatu, Inc, CNRS, D-Wave Systems Inc., Genocea, HRL Laboratories, Hycrete Inc., Imagel Ltd, Nano Competing Technologies, Inc., Nano Gram Corporation, Nanologica, National Institute for Materials Science, Tsukuba, Japan, Northwestern University, Saint-Gobain Corporation, Unidym
Nanologica is shortlisted for the international price World Technology Award in association with TIME, Fortune, and Science magazine.
The World Technology Network, that hands out the prize consists of approximately 1,000 members from 60 countries. The theme for this year's nominations is "How to save the future". The purpose of the awards ceremony is to reward the world's most innovative individuals and companies. At this year's World Technology Summit & Awards Nanologica was nominated in the category: Materials (corporate). Past winners in this class are Dow Chemical, IBM, Molecular Inprints and Nanosys. In the past year, Nanologica won numerous prestigious prizes for its technology, including Sustainable 100 Award and New Materials Forum Best Presentation Award."It is highly honorable that our work gets attention internationally. We have for several years worked with leading international academic and industrial partners and customers and it feels good that this work is now recognized by the World Technology Network", says Krim Talia, CEO Nanologica
Nanologica is a materials development company specializing in developing innovative nano-porous materials for a variety of applications (from Diagnostics and Drug Delivery to Solar cells). The company was founded in Uppsala in 2004 and its unique technology is based on nanotechnology research from Stockholm University and the Ångström Laboratory at Uppsala University. Nanologica's technology enables the creation of nano-porous materials with new properties as a function of material composition, size, and structure.
The importance of materials stuctures can be observed around us every day. An interesting example is carbon, depending on the atomic structure it can take the form of graphite (which is one of the softest existing substances) or diamond (which is one of the hardest). Achievements in nanotechnology allows scientists to, by intelligent design of materials on an atomic level, create materials with superior properties for specific target applications.
"We have with the support from Vinnova, Innovationsbron and a number of bold business angels taken our fundamentally new research from innovation to commercially viable products - a process that requires both research excellence and business sustainability. We have now reached a commercial breakthrough in a number of our application areas, and this nomination is proof that we draw attention far beyond the borders of Sweden", says Krim Talia, CEO Nanologica
Nanologica is developing materials for applications for the health-care and energy sectors. Nanologica's materials are used in diagnostic applications where nano porous particles have been functionlised with different fluorescent molecules that are then conjugated with antibodies to act as markers in diagnostic tests and analysis. Nanologica's material is also used as substrate for drug delivery in a collaborative project with one of the world's five largest pharmaceutical companies. The specific Nanologica material that is used in this process is called In vivo, and is now tested for constructing molecules that require a controlled delivery over a longer period than one week.
For the energy sector Nanologica has developed and patented materials and technology that significantly increases the efficiency of third generation solar cells. Nanologica material creates a turbo efficient in transparent DSSC solar cells which opens up new opportunities for integration of solar cells in for example skyscrapers and translucent windows applications. This technology has an important role to play in the overall trend towards environmentally sustainable buildings. The technology is commercialised by the Nanologica subsidiary NLAB Solar. For more information visit www.nlabsolar.com ;
World Technology Network (WTN) is in association with TIME magazine, Fortune magazine, Science magazine, the NASDAQ / OMX, Mayo Clinic, Advance Science Serving Society and the New York Academy of Sciences. WTN consists of 1,000 members from 60 countries. Its members are focused on the business and science of bringing important emerging technologies of all types (from biotech to new materials, from IT to new energy sources) into reality. WTN was created to encourage serendipity and is an elite network of people working to change the world. For more information visit www.wtn.net ;
Nominated in the category Materials (corporate):
Cambrios Technologies, Canatu, Inc, CNRS, D-Wave Systems Inc., Genocea, HRL Laboratories, Hycrete Inc., Imagel Ltd, Nano Competing Technologies, Inc., Nano Gram Corporation, Nanologica, National Institute for Materials Science, Tsukuba, Japan, Northwestern University, Saint-Gobain Corporation, Unidym